Company intelligence / Profile preview

Innoventric

Ownership: Private
Development stage: Phase 1

Overview

Innoventric has developed a novel cross-caval transcatheter approach to treat tricuspid regurgitation. Its lead product, the Trillium™ technology, enables functional tricuspid valve replacement by using the caval veins as fixation sites rather than relying on the native valve. The first-in-human European clinical trial has seen over 10 successful implantations with a reported technical success rate of 100%, no aborted procedures, migrations, or fractures. Implantation time is under 15 minutes. The Unica™ device has also been implanted successfully in at least one case as of September 2024.

Therapeutic areas: Cardiovascular
Modalities: DeviceBiologic (device interacts with biological systems but is not a drug or biologic itself)
Industry: Implantable Medical Devices

Drug pipeline

2 assets

Trillium

Phase 1

Indications: Tricuspid regurgitation

1 more asset in the full pipeline.

Request access →

Partnerships

Horizon Europe grant from European CommissionUS-based and European investors participated in Series A funding round

Beyond the preview

Go deeper on Innoventric.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Innoventric.

Explore the full profile